XPH Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.35% | Return% 1Y | 31.91% | Total Holdings | 64 | Perf Week | 0.92% | Volume | 94,522 |
| Asset Type | Equities (Stocks) | AUM | $448M | Return% 3Y | 21.65% | NAV | $63.93 | Perf Month | -2.33% | Avg Volume | 0.16M |
| ETF Type | US Equities | Dividend TTM | $0.28 (0.43%) | Return% 5Y | 7.32% | 52W High | -13.18% | Perf Quarter | -7.44% | Rel Volume | 0.58 |
| Active/Passive | Passive | Div Gr. 3/5Y | -11.55% 13.67% | Return% 10Y | 5.33% | 52W Low | 35.61% | Perf Half Y | 14.17% | Prev Close | $63.96 |
| IPO | 2006/6/22 | Flows% 1M | -14% | Return% SI | 8.94% | RSI (14) | 50.51 | Perf YTD | 15.25% | Price | $64.55 |
| Beta | 0.63 | Flows% 3M | 0.09% | Flows% YTD | 71.14% | Flows% 1Y | 85.33% | Perf Year | 32.06% | Volatility(W/M) | 1.78% 2.09% |
| SMA20 | 1.9% | SMA50 | -3.57% | SMA200 | 4.69% | ATR | 1.33 | ||||
SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
The top 10 make up 29% of the fund
Spread evenly across many holdings.
DFTX Definium Therapeutics Inc 3.09% 3 
MBX MBX Biosciences Inc 2.72% 4 
ALMS Alumis Inc 2.14% 5 
ATAI AtaiBeckley Inc 2.13% 6 
TRVI Trevi Therapeutics Inc 2.12% 7 
ELVN Enliven Therapeutics Inc 2.09% 8 
AMLX Amylyx Pharmaceuticals Inc 2.04% 9 
MANE VeraDermics Inc 2.02% 10 
LGND Ligand Pharmaceuticals Inc 1.94% Largest sectors first.
Over the past 1 year, roughly in the middle
13% below its 1-year high.
Traded less than usual. That is 58% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +35.1%. The S&P 500 did +69% over the same period.
Tap to view numbers
The price swings a lot
At its worst (December 2015) it fell 38% and took 267 days to recover.
Tap to view numbers
The dividend is on the small side
Pays 0.43% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 85.3% of assets came in.
Tap to view numbers
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 99M 
PILL Direxion Daily Pharmaceutical & Medical Bull 3X ETF 15M 
VFH Vanguard Financials ETF 0.09% 
ONEQ Fidelity Nasdaq Composite Index ETF 0.21% 
VIS Vanguard Industrials ETF 0.09% 
FV First Trust Dorsey Wright Focus 5 ETF 0.89% 
IYF iShares U.S. Financials ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
FAQ
How many holdings does XPH have?
XPH holds a total of 64 securities, with an AUM of approximately $448M.
Does XPH pay dividends (distributions)?
XPH's distribution yield is approximately 0.43%.
What is the 52-week high and low for XPH?
XPH has recorded a 52-week high of $74.35 and a low of $47.60.
